Riding the Surge in Health Management: Capturing Opportunities in a Trillion-Dollar Market

In 2020, the outbreak of the COVID-19 pandemic heightened public awareness of health issues, leading to a surge in health consciousness. Consequently, the demand for health management among the general population has become increasingly personalized, complex, and diversified. With the continuous advancement of “Internet + Healthcare” policies, empowering individual health through innovative health management in the post-pandemic era has become an inevitable trend. Driven by growing market demand and strong policy support,Health Management Emerges as a Blue Ocean for Innovation and Entrepreneurship。

In this context,VCBeatScheduled forMorning of April 18, 2021, heldThe 5th Future Healthcare Top 100 Conference · Health Management Innovation Forum, jointly exploring how to deeply advance the new ecosystem and upgraded landscape of the health management industry, and addressing key issues such as how the industry will achieve more stable and rapid development in the future, driven directly by new technologies, new concepts, and new policies.

Confirmed Participating Companies at the 5th Future Healthcare Top 100 Conference:Microsoft, Intel, IBM, BOE, Ali Health, AstraZeneca, Takeda Pharmaceutical, Sanofi, GE, Roche, Terumo, Medtronic, New Horizon Health, Langzi Shares, Clarivate, Agilent, Livongo, Hims & Hers, BGI Group, JD Health, Sansure Biotech, Tigermed, Dian Diagnostics, KingMed Diagnostics, Wondfo, Winning Health Technology Group, Donghua Software, Genetron Health, Imeik, Bairong Medicaletc.

>>>> Specific Topics of the Forum 

Guest：Yang Wenlin | CPO and Group Vice President, Zhiyun Health

Proposed Agenda：The “China Model” of Internet-Plus Chronic Disease Management

Due to fundamental differences between the healthcare systems in China and the United States, Chinese companies cannot simply replicate the business models of U.S. digital health firms. Achieving localized innovation and establishing a “Chinese model” for “Internet Plus” chronic disease management has become the primary focus of exploration for domestic chronic disease management companies.

Guest：Li Qi | Deputy General Manager, Pacific Health Management Co., Ltd.

Proposed Agenda：“Insurance+” Empowers Diversified Collaboration in the Health Management Industry

Driven by the dual forces of policy support and the healthcare consumer market, health insurance has become the fastest-growing segment within the insurance industry. To promote innovative development in the health industry and break through into the billion-dollar blue ocean market of health insurance, diversified collaboration is key.

Guest:Wang Xu | AiDeputy General Manager of Kang Group & Deputy General Manager of Daoyitong Operations

Proposed Agenda:Algorithmic Dual-Channel Healthcare Model Leads the Medical IndustryJianxin Innovation

This year’s Government Work Report proposed for the first time to “promote standardized development.” This signifies that as internet healthcare transitions from its exploratory phase into a period of rapid growth, determining how to achieve new industry development has become a central imperative.

Guest：Li Yuxin | Founder and Chairman of Health Beneficial

Proposed Agenda：Deepening Smart Health to Foster a New Paradigm for Urban Health Industry Development

Research has found a correlation between citizens' health habits and economic development. As the overall economic level of cities rises, citizens' incomes and health awareness continue to improve. Leveraging digital technology to promote smart health effectively alleviates the patient load on offline medical institutions, thereby facilitating the upgrading of the urban health industry.

Guest:Cao Xueli | CEO of Shangyi Renjia

Proposed Agenda:A New Model of Full-Course TCM Health Management Empowered by Big Data

A New Model of Health Management Centered on Health and Characterized by Traditional Chinese Medicine (TCM) ServicesThis model is guided by TCM theories, supported by digital technologies and the “Internet+” framework, integrated with modern health management concepts, and achieves the convergence of online and offline services. It provides personalized, convenient, shared, precise, and intelligent TCM health services to promote residents’ health and advance the inheritance and development of Traditional Chinese Medicine.

Guest：Ma Ji | Co-founder and Chief Medical Officer of the Yilianjia Platform

Proposed Agenda：IoT-Driven Innovation in Home Healthcare Services

In certain areas of smart healthcare, the core of the Internet of Things (IoT) lies in digitizing both device operations and user behavior, and integrating these data with large-scale cloud computing capabilities. In the future, it is expected that more traditional medical instruments will achieve “intelligent connectivity” by going online, thereby integrating the service industry chain—a trend that is set to become increasingly prominent.

Guest：Pan Tao | Co-founder of Huichang Cloud Medical

Proposed Agenda：The Future of Smart, Precision Management of Chronic Respiratory Diseases

Chronic respiratory diseases are one of the four major chronic diseases globally and rank as the third leading cause of death in China. Abroad, specialized medical institutions provide long-term management services for patients with chronic respiratory conditions, whereas this field remains largely undeveloped in China. Therefore, it is worth exploring in depth the future trends of intelligent, precision-based management of chronic respiratory diseases.

Guest:Yu Jurong | Partner, Heju Yinuo Big Health Industry Fund; Yue Hongwen | Dean, Boao Yiling Cardiovascular Hospital; Li Yuxin | Founder and Chairman, Health Beneficial;Wang Xu | Deputy General Manager of iKang Group and Deputy General Manager of Operations at Daoyitong;Liu Yan | Founder of Anhe Health; Cao Xueli | CEO of Shangyi Renjia; Li Shuo | Co-founder & COO of Baoxian Geek;

Proposed Agenda：Surging Trends: Opportunities and Challenges Amid Industrial Leapfrogging

The pandemic “black swan” has propelled the entire healthcare industry into a new phase of development. With heightened public health awareness and a surge of supportive national policies, the medical and health management sector is facing unprecedented upgrades and challenges.

April 16-18, 2021，VCBeatJointPeople's Government of Wujiang District, Suzhou City、Guangdong Zhong Nanshan Medical Foundation、Suzhou Wujiang Dongfang State-owned Capital Investment and Operation Co., Ltd.AtSuzhou · WujiangCo-hosted byThe 5th Future Healthcare Top 100 Conference. The conference will focus on the healthcare industry, with attention to individual health, public hygiene, the medical industry chain, and supporting infrastructure systems. For the first time, it will explore the industrial ecosystem of the conference, connecting more possibilities in healthcare and achieving a comprehensive upgrade of the Top 100 Conference.

>>>>  Partially Confirmed Guests

Zhang Zhiyuan| Academician of the Chinese Academy of Engineering

Shiqing Chen| Member of the U.S. National Academy of Engineering, Supercomputing Expert

Li Changming| Dean of the School of Materials Science and Engineering, Suzhou University of Science and Technology; Academician of Academia Europaea

Timothy Johns | Digital Health Officer, British Consulate-General in Shanghai

Song Yijun| Representative of the Government of Ontario, Canada; Commercial Counsellor, Canadian Embassy in China

Sun Baoqing| Chairman of the Zhong Nanshan Medical Foundation of Guangdong Province

Nick Rodgers| Chair of the South East Academic Medical Systems for Technology (SEAMSTech), Chair of Destiny Pharma

Wang Tianmiao| Professor, Beihang University

Wang Jingjing| Executive Director, Global Health Industry Innovation Center, Tsinghua University

Jane Jin | Head of Oxford University Innovation, China Region

Zhi Zhang | Business Development Manager, Technology Division, UK Medical Research Council |

Chen Fangxia| Director of Business Development, Asia Technology Transfer Center, Western University, Canada

Kimon Angelides | Founder, Livongo & Vivante

Luo Zhangwei| Chief Scientist, Suzhou Smart Healthcare Innovation Center; Former Chief AI Scientist, Siemens China Research Institute, Suzhou Branch

Liu Enmei| Vice President, Children's Hospital of Chongqing Medical University (Liangjiang Campus)

Chen Hongxiang| Executive Vice President, Union Shenzhen Hospital of Huazhong University of Science and Technology (Nanshan Hospital)

Tao Liang| President of Wuhan Asia Heart Hospital

Zhang Nuofu| Vice President of the First Affiliated Hospital of Guangzhou Medical University

Weng Jianping| Deputy Director of the Division of Life Sciences and Medicine, University of Science and Technology of China; President of Bengbu Medical College

Lei Juan| Deputy Director, West China Transfer Center, West China Hospital, Sichuan University

Wei Xuejie| Vice President of Xuzhou Mining Group General Hospital

Ye Xin| Deputy Dean of Yilianzhong Beijing Research Institute

Wu Xia| Managing Director, CICC Capital

Zhang Man| Vice President, China Renaissance

Wang Xiaohui| Managing Partner, Shengjing Jiacheng Fund of Funds

Hu Chuanwei| Vice President, Hengqin Golden Investment Group

Li Yuhui| Founding Managing Partner, Panlin Capital

Yu Zhengkun| Founding Partner of Jifeng Capital

Zhou Yi| Partner, Shenzhen Capital Group Healthcare Industry Fund

Tian Min| Partner, Yuanjing Capital

Tang Haofu| Chairman of Chuangrui Investment

Ren BoIce| Executive Director, Sinovation Ventures

Andrew Craig| WG Fund Partner

……

>>>> Conference Highlights

Star-Studded Guest Lineup — Led by Academician Scientists200+Industry Leaders Present Three Days of Cutting-Edge Medical Technology, Industry Trends, and Business Innovation

Business Wisdom of Industry Leaders——40Leading Listed Companies Unveil Strategic Roadmaps: Insights into the Industry’s Future and Innovation Landscape

Global Perspective and Overseas Resources—FromUnited Kingdom, Israel, United States, Canada, Belgium, Germany, Denmark...and the industrial development trends and capital markets of multiple countries, linking high-quality overseas technological innovation projects

In-Depth Insights into Niche Sectors — Major Release7 copiesIndustry Research Series: Exploring Development Opportunities and Innovative Cases in Niche Sectors

Gathering the Core Forces of Future Healthcare — Release6 MajorTop 100 Lists and Awards, Converged1000+Unicorns and High-Potential Innovative Enterprises Jointly Explore Pathways for Innovation-Driven Development

Emphasizing the Translation of Scientific Research Achievements — Invitation10+Hospital Presidents, Research Experts, and University Scholars: Breaking Boundaries to Explore the Integration of Industry and Research

A Forward-Looking Capital Perspective——100+Featuring forward-looking investors from GP, LP, CVC, VC, PE, FA, and other financial institutions to gauge the direction of capital heat in the industry

Harnessing the Momentum of the Industrial Ecosystem——10+Ecosystem Conference for Investment Institutions and Industry Giants: Promoting Industrial Ecosystem Integration and Fission

http://vb100.vcbeat.top/

Click the link or scan the QR code to view conference details and purchase tickets.

In recent years, Wujiang has seized new opportunities presented by the latest round of industrial transformation, vigorously fostering the development of the life and health industry. The sector has begun to take shape, giving rise to a large number of leading enterprises, including Zhonghe Biotechnology, Shengda Pharmaceutical, Haian Pharmaceutical, Jiecheng Medical, Langkai Medical, Junmeng Biotechnology, Chukai Medicine, Weikang Biotechnology, and Novoprotein. A number of scientific and technological achievements have entered clinical trial and industrialization stages. Looking ahead, Wujiang District will focus on key areas such as pharmaceutical biotechnology, novel medical devices, and comprehensive health services, actively building an integrated full-industry-chain system encompassing “R&D innovation—pilot-scale acceleration—industrialization.”